David McErlane

DAVID MCERLANE
GROUP PRESIDENT, BIOLOGICS

David McErlane joined Catalent as Group President of Biologics in September 2023 as a member of Catalent’s executive leadership team. In this role, he leads all of Catalent’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.

Prior to joining Catalent, Mr. McErlane served as senior vice president and business unit head for Lonza’s Bioscience business – where he led strategy, sales, marketing, innovation, digital, and operations functions for this division while developing transformational business strategies, executing major investments to digitize the customer journey, and acquiring and integrating new technologies.

Earlier in his career, Mr. McErlane held several leadership positions at MilliporeSigma and BioReliance after beginning his career as an engineering manager at Zeneca. He holds a bachelor’s degree in electronic systems engineering from Glasgow Caledonian University.